Apnimed, Inc. (NASDAQ:APMD – Get Free Report) major shareholder Morningside Venture Investment bought 312,500 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were bought at an average cost of $16.00 per share, for a total transaction of $5,000,000.00. Following the completion of the transaction, the insider directly owned 7,152,713 shares of the company’s stock, valued at $114,443,408. This trade represents a 4.57% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
Apnimed Stock Performance
Shares of NASDAQ APMD opened at $26.51 on Thursday. Apnimed, Inc. has a 12 month low of $16.12 and a 12 month high of $29.15.
See Also
- Five stocks we like better than Apnimed
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Apnimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apnimed and related companies with MarketBeat.com's FREE daily email newsletter.
